Novocure is a global oncology business with subsidiaries in the U.S., Europe, and Asia. Novocure’s mission is to improve the lives of cancer patients through the development and commercialization of Tumor Treating Fields (TTFields) as the next major treatment modality in cancer, adding to surgery, radiation and chemotherapy. Novocure’s U.S. operations are based in New York, NY and Portsmouth, NH with European operations based in Luzerne, Switzerland and Asian operations based in Tokyo, Japan. The company’s research center is in Haifa, Israel.
Yoram Palti, MD, PhD is credited with discovering the effect of intermediate frequency electric fields on cell division. His research led to the formation...
Novocure is led by a team of senior executives who are bound by a shared passion to improve the lives of cancer patients through the development...
The Novocure Board of Directors brings a wealth of oncology, medical device and capital markets experience to the table, providing valuable guidance...